이벤트 소개
关于活动
イベント情報
2025 is looking to be another year of surging growth of the ADC field in Asia, with a growing number of pioneering companies forming year on year, plus more ADC developers in Asia advancing into clinical trials each year than both Europe and the US.
The 4th World ADC Asia is the only ADC event in Asia to provide breadth and depth of insights across all aspects of ADC development from discovery, all the way through in to manufacturing, with brand new pre-conference Seminar Days covering ADC fundamentals, Bispecific ADCs, and Regulatory CMC, ensuring there is something for everyone no matter their expertize or experience.
As the Asian ADC market establishes itself as a hub of ADC As the Asian ADC market establishes itself as a hub of ADC development and the world waits to see the results of recent innovation from the region in the form of clinical validation, World ADC Asia is the ADC event you should prioritize in 2025.
What’s New for 2025?
2025년의 새로운 점은 무엇인가요?
2025年有什么新变化？
2025年の新しい内容は何ですか？
1
A Bispecific ADC Seminar Day to explore how to leverage the enhanced target specificity and drug internalization of bispecific ADCs by understanding their key design considerations and examining target selection and translation to the clinic
2
A Discovery Track showcasing the future of antibody-drug conjugates by exploring innovative target discovery, linker-payload technologies, and new targeting formats. This track is ideal for discovery scientists and research teams aiming to identify novel ADC targets, optimize linker chemistry and payload selection to enhance ADC stability, efficacy, and safety, as well as explore dual-payload ADC strategies to overcome resistance and expand therapeutic windows
3
A Preclinical & Clinical Development Track to accelerate ADCs from concept to clinic with practical strategies and lessons learned. Tailored for preclinical and translational scientists, as well as clinicians, this track will cover modeling, patient selection, biomarker integration, reverse translational strategies to minimize ADC toxicities, and breakthrough clinical data for dual-payload and bispecific ADCs.
4
Ensure the scalability, consistency, and regulatory success of your ADC programs with our CMC Track & Regulatory CMC Day, designed for analytical, process development, regulatory, and quality teams. This track will address ADC manufacturing challenges, from linker-payload conjugation to large-scale production, and delve into critical quality attributes and process validation strategies for fast regulatory approval
5
Our Introduction to ADCs Seminar Day – Ideal for newcomers, this session lays the foundation for understanding ADCs. Explore early insights that shaped modern programs, familiarize yourself with linker, payload, and target selection, and learn strategies that helped early investigators overcome key challenges. This seminar equips participants with the basics to navigate and contribute to the evolving ADC landscape
6
Join our Bispecific ADC Seminar Day to explore innovations advancing ADC capabilities. This seminar covers key considerations for aligning target biology with optimal bispecific formats, design strategies to reduce toxicity, and approaches to enhance efficacy. Participants will gain insights into strategies for successfully transitioning bispecific ADCs to the clinic.
7
Partnering & Licensing Content – Explore strategies and opportunities in ADC partnering and licensing across the Asian market. Gain insights into what makes ADC licensing deals attractive, learn best practices for managing cross-cultural collaborations, and discover how global pharma companies assess ADC assets from Asian firms to unlock strategic value
Who Will You Meet?
Pioneering ADC developers across China, Japan, Singapore, Taiwan and other APAC regions alongside industry leaders from the US and Europe.
